Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Citi
McKesson
Queensland Health
Cerilliant
Express Scripts
Colorcon
Julphar

Generated: July 17, 2018

DrugPatentWatch Database Preview

Cidofovir - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for cidofovir and what is the scope of cidofovir patent protection?

Cidofovir
is the generic ingredient in two branded drugs marketed by Emcure Pharms Ltd, Mylan Institutional, and Gilead Sciences Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for cidofovir. Three suppliers are listed for this compound.
Pharmacology for cidofovir
Synonyms for cidofovir
({[(2S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
(S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(S)-HPMPC; Cidovir
[(1S)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
[1-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-propan-2-yl]oxymethylphosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
113852-37-2
120362-37-0 (hydrochloride salt)
394C661
768M1V522C
AB01566823_01
AC-1666
AC1L1TLB
AC1Q6C68
AKOS005145721
AKOS015854828
AN-14714
AN-8255
anhydrous cidofovir
API0002008
BC209905
BCP0726000147
BCP9000528
BDBM31915
BG0579
C8H14N3O6P
CAS-113852-37-2
CC0162
CDV
CHEBI:3696
CHEMBL152
Cidofovir (anhydrous)
Cidofovir (Vistide)
Cidofovir [INN]
Cidofovir anhydrous
Cidofovir gel
Cidofovir hydrate
cidofovir monophosphate
Cidofovir, anhydrous
Cidofovir,Vistide
Cidofovir(anhydrous)
Cidofovir(Vistide)
Cidofovirum
cidovir
CS-1669
D04AAW
DB00369
DSSTox_CID_23734
DSSTox_GSID_43734
DSSTox_RID_80069
DTXSID3043734
EBD21562
Forvade
Forvade (TM)
FT-0623818
GS 0504
GS 504
GS-0504
GS-504
GS-6438
GS504
HPMPC
HSDB 7115
HY-17438
J-502695
KB-302539
KS-00000XN7
L8P
LS-106432
MFCD00866936
MFCD17215968
MLS003915629
NCGC00184994-01
NCGC00184994-02
NCGC00184994-03
NSC-742135
NSC742135
Phosphonic acid, ((2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, (S)-
Phosphonic acid, [[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-
Phosphonic acid,[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-
s1516
SCHEMBL3948
sidofovir
SMR002544687
SR-01000931969
SR-01000931969-2
Tox21_112994
UNII-768M1V522C
Vistide
Vistide (TN)
Vistide, Cidofovir
VWFCHDSQECPREK-LURJTMIESA-N
ZINC1530600

US Patents and Regulatory Information for cidofovir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional CIDOFOVIR cidofovir INJECTABLE;INJECTION 201276-001 Jun 27, 2012 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Emcure Pharms Ltd CIDOFOVIR cidofovir INJECTABLE;INJECTION 202501-001 Jul 26, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gilead Sciences Inc VISTIDE cidofovir INJECTABLE;INJECTION 020638-001 Jun 26, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cipla
Moodys
Medtronic
Healthtrust
Express Scripts
Chinese Patent Office
Dow
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.